Glen Scarbrough, MD
Obstetrics & Gynecology · Savannah, GANPI 1164469177
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.9% of the total across 139 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $560 and has fallen 65.3% since, to $195 in 2025.
Across 139 payments — averaging $19.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$345
- AbbVie$318
- Mayne Pharma Commercial LLC$276
- Sumitomo Pharma America, Inc.$184
- Channel Medsystems, Inc.$148
- Astellas Pharma US Inc$147
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,54196%
- Education$1094%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 21 | $345 |
| AbbVie(2 entities) | 19 | $318 |
| Mayne Pharma Commercial LLC | 10 | $276 |
| Sumitomo Pharma America, Inc. | 8 | $184 |
| Channel Medsystems, Inc. | 2 | $148 |
| Astellas Pharma US Inc | 8 | $147 |
| Hologic Sales And Service, LLC | 8 | $145 |
| Therapeuticsmd, Inc. | 9 | $127 |
| Myovant Sciences Inc. | 6 | $127 |
| Davol Inc. | 3 | $101 |
| Amgen | 7 | $101 |
| AMAG Pharmaceuticals, Inc. | 5 | $95 |
| Evofem Biosciences, Inc. | 5 | $83 |
| Exeltis, USA Inc. | 4 | $67 |
| Millicent US Inc | 3 | $51 |
| Scynexis, Inc. | 3 | $51 |
| Pfizer | 2 | $41 |
| Mylan Pharmaceuticals Inc. | 2 | $37 |
| Dexcom, Inc. | 1 | $29 |
| Agile Therapeutics, Inc. | 2 | $25 |
| Avion Pharmaceuticals | 2 | $24 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Sage Therapeutics, LLC | 1 | $16 |
| Smith+Nephew | 1 | $15 |
| Lupin Inc. | 1 | $15 |
| Radius Health, Inc. | 1 | $15 |
| Ferring Pharmaceuticals Inc. | 1 | $14 |
| Axonics, Inc. | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
| GSK | 1 | $12 |
How this compares
$2,649 in reported general payments places this provider in the 75th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 101 | $3,498 |
| Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet | 29 | $2,492 |
| FyavolvNorethindrone Ac/Eth Estradiol | 11 | $1,117 |
| Ibandronate Sodium | 56 | $928 |
| Norethindron-Ethinyl EstradiolNorethindrone Ac/Eth Estradiol | 11 | $406 |
| ValacyclovirValacyclovir Hcl | 12 | $332 |
| Fluconazole | 16 | $105 |
| Citalopram HbrCitalopram Hydrobromide | 15 | $98 |
| Alprazolam | 25 | $61 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Savannah
- Dina LinfootSavannah$12K
- Michael JacksonSavannah$9K
- Edmund KimLawrenceville$628K
- Jacquelin WaltersDuluth$147K
- Nicole SparksJohns Creek$121K
- Lethenia BakerThomaston$111K
- Renee AllenAtlanta$74K
- Matthew RalstenFayetteville$64K
- Murray FreedmanAugusta$48K
- Tosha Rogers-JonesAtlanta$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.